231 related articles for article (PubMed ID: 21602551)
1. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
[TBL] [Abstract][Full Text] [Related]
3. Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
Dutta NK; Alsultan A; Gniadek TJ; Belchis DA; Pinn ML; Mdluli KE; Nuermberger EL; Peloquin CA; Karakousis PC
Antimicrob Agents Chemother; 2013 Aug; 57(8):3910-6. PubMed ID: 23733473
[TBL] [Abstract][Full Text] [Related]
4. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
[TBL] [Abstract][Full Text] [Related]
5. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
[TBL] [Abstract][Full Text] [Related]
6. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
7. Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
Ibrahim M; Truffot-Pernot C; Andries K; Jarlier V; Veziris N
Am J Respir Crit Care Med; 2009 Sep; 180(6):553-7. PubMed ID: 19590024
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
Front Immunol; 2020; 11():680. PubMed ID: 32411131
[TBL] [Abstract][Full Text] [Related]
9. Statin adjunctive therapy shortens the duration of TB treatment in mice.
Dutta NK; Bruiners N; Pinn ML; Zimmerman MD; Prideaux B; Dartois V; Gennaro ML; Karakousis PC
J Antimicrob Chemother; 2016 Jun; 71(6):1570-7. PubMed ID: 26903278
[TBL] [Abstract][Full Text] [Related]
10. Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.
Lenaerts AJ; Hoff D; Aly S; Ehlers S; Andries K; Cantarero L; Orme IM; Basaraba RJ
Antimicrob Agents Chemother; 2007 Sep; 51(9):3338-45. PubMed ID: 17517834
[TBL] [Abstract][Full Text] [Related]
11. Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
Hu Y; Pertinez H; Liu Y; Davies G; Coates A
J Antimicrob Chemother; 2019 Jun; 74(6):1627-1633. PubMed ID: 30789209
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis.
Montgomery SA; Young EF; Durham PG; Zulauf KE; Rank L; Miller BK; Hayden JD; Lin FC; Welch JT; Hickey AJ; Braunstein M
PLoS One; 2018; 13(9):e0204495. PubMed ID: 30261007
[TBL] [Abstract][Full Text] [Related]
13. Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
Rosenthal IM; Zhang M; Williams KN; Peloquin CA; Tyagi S; Vernon AA; Bishai WR; Chaisson RE; Grosset JH; Nuermberger EL
PLoS Med; 2007 Dec; 4(12):e344. PubMed ID: 18092886
[TBL] [Abstract][Full Text] [Related]
14. Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.
Dutta NK; Pinn ML; Zhao M; Rudek MA; Karakousis PC
J Antimicrob Chemother; 2013 Jun; 68(6):1327-30. PubMed ID: 23463208
[TBL] [Abstract][Full Text] [Related]
15. Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.
Hoff DR; Ryan GJ; Driver ER; Ssemakulu CC; De Groote MA; Basaraba RJ; Lenaerts AJ
PLoS One; 2011 Mar; 6(3):e17550. PubMed ID: 21445321
[TBL] [Abstract][Full Text] [Related]
16. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
17. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model.
Eckhardt E; Li Y; Mamerow S; Schinköthe J; Sehl-Ewert J; Dreisbach J; Corleis B; Dorhoi A; Teifke J; Menge C; Kloss F; Bastian M
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0143822. PubMed ID: 36975792
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.
Clemens DL; Lee BY; Silva A; Dillon BJ; Masleša-Galić S; Nava S; Ding X; Ho CM; Horwitz MA
PLoS One; 2019; 14(5):e0215607. PubMed ID: 31075149
[TBL] [Abstract][Full Text] [Related]
20. Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
Liu Y; Pertinez H; Ortega-Muro F; Alameda-Martin L; Harrison T; Davies G; Coates A; Hu Y
J Antimicrob Chemother; 2018 Mar; 73(3):724-731. PubMed ID: 29244108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
